HDGF expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.944200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.595400E-01
Normal-vs-Stage2
1.451000E-01
Normal-vs-Stage3
6.407000E-01
Normal-vs-Stage4
2.282200E-01
Stage1-vs-Stage2
3.735800E-01
Stage1-vs-Stage3
9.374400E-01
Stage1-vs-Stage4
4.505200E-01
Stage2-vs-Stage3
3.913200E-01
Stage2-vs-Stage4
6.478600E-01
Stage3-vs-Stage4
4.607000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.292800E-01
Normal-vs-AfricanAmerican
8.962500E-02
Normal-vs-Asian
5.041600E-02
Caucasian-vs-AfricanAmerican
5.679400E-01
Caucasian-vs-Asian
1.370030E-01
AfricanAmerican-vs-Asian
5.720600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.730400E-01
Normal-vs-Female
2.256000E-01
Male-vs-Female
6.892200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.903600E-01
Normal-vs-Age(41-60Yrs)
1.153580E-01
Normal-vs-Age(61-80Yrs)
2.522600E-01
Normal-vs-Age(81-100Yrs)
1.371830E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.877980E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.524400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.423600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.423200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.723600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.941400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.420000E-01
Normal-vs-Daily Drinker
3.309200E-01
Normal-vs-Weekly Drinker
8.153800E-02
Normal-vs-Occasional Drinker
5.832000E-02
Normal-vs-Social Drinker
2.565800E-01
Non Drinker-vs-Daily Drinker
6.731200E-01
Non Drinker-vs-Weekly Drinker
1.692770E-01
Non Drinker-vs-Occasional Drinker
2.545700E-02
Non Drinker-vs-Social Drinker
8.563000E-01
Daily Drinker-vs-Weekly Drinker
4.104400E-01
Daily Drinker-vs-Occasional Drinker
1.162200E-01
Daily Drinker-vs-Social Drinker
5.590200E-01
Weekly Drinker-vs-Occasional Drinker
4.421600E-01
Weekly Drinker-vs-Social Drinker
1.021230E-01
Occasional Drinker-vs-Social Drinker
2.240300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.378000E-01
Normal-vs-Grade 2
3.057400E-01
Normal-vs-Grade 3
6.501200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.501300E-03
Grade 1-vs-Grade 3
5.818000E-04
Grade 1-vs-Grade 4
8.378000E-01
Grade 2-vs-Grade 3
4.895200E-01
Grade 2-vs-Grade 4
3.057400E-01
Grade 3-vs-Grade 4
6.501200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.647000E-01
Normal-vs-NonDiabetic
1.673420E-01
Diabetic-vs-NonDiabetic
2.378000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.191700E-02
Normal-vs-NoPancreatitis
2.397400E-01
Pancreatitis-vs-NoPancreatitis
1.183780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.715560E-01
Normal-vs-N1
1.783420E-01
N0-vs-N1
6.516000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.597400E-03
Normal-vs-TP53-NonMutant
4.140800E-01
TP53-Mutant-vs-TP53-NonMutant
5.8042000095071E-09
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
